CCO Stock Overview
The Calmer Co International Limited operates as a medicinal kava health and wellness company in Australia, New Zealand, Fiji, and the United States.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
The Calmer Co International Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.005 |
52 Week High | AU$0.007 |
52 Week Low | AU$0.0035 |
Beta | 1.55 |
1 Month Change | 25.00% |
3 Month Change | 11.11% |
1 Year Change | n/a |
3 Year Change | -95.24% |
5 Year Change | -93.59% |
Change since IPO | -95.83% |
Recent News & Updates
Recent updates
Shareholder Returns
CCO | AU Personal Products | AU Market | |
---|---|---|---|
7D | 25.0% | 1.5% | 1.8% |
1Y | n/a | -12.9% | 7.0% |
Return vs Industry: Insufficient data to determine how CCO performed against the Australian Personal Products industry.
Return vs Market: Insufficient data to determine how CCO performed against the Australian Market.
Price Volatility
CCO volatility | |
---|---|
CCO Average Weekly Movement | 23.2% |
Personal Products Industry Average Movement | 5.3% |
Market Average Movement | 9.0% |
10% most volatile stocks in AU Market | 17.2% |
10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: CCO's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine CCO's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | n/a | Anthony Noble | www.thecalmerco.com |
The Calmer Co International Limited operates as a medicinal kava health and wellness company in Australia, New Zealand, Fiji, and the United States. It produces and sells noble kava extract capsules, root powder mixes, and teas under the Fiji Kava brand; hemp and CBD oils under Danodan brand; drinking kava and flavoured shots under the Taki Mai brand; and kava beverages under leilo brand names. The company also produces nutraceuticals; and sells t-shirts.
The Calmer Co International Limited Fundamentals Summary
CCO fundamental statistics | |
---|---|
Market cap | AU$5.91m |
Earnings (TTM) | -AU$4.50m |
Revenue (TTM) | AU$2.46m |
2.4x
P/S Ratio-1.3x
P/E RatioIs CCO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CCO income statement (TTM) | |
---|---|
Revenue | AU$2.46m |
Cost of Revenue | AU$1.81m |
Gross Profit | AU$652.64k |
Other Expenses | AU$5.16m |
Earnings | -AU$4.50m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0038 |
Gross Margin | 26.51% |
Net Profit Margin | -182.94% |
Debt/Equity Ratio | -501.1% |
How did CCO perform over the long term?
See historical performance and comparison